Testing of blood products for pathogenic agents is an important pillar of blood product safety. Researchers of the Paul-Ehrlich-Institut (PEI) have extended the repository of reference strains for the testing of platelet concentrates (white blood cells) as part of their role as Collaborating Centre for the World Health Organization by ten bacterial strains. That way, 14 bacterial strains are now available for the use in the validation of test systems worldwide. The first four reference strains, too, were developed within the responsibility of the PEI. Vox Sanguinis reports on the extension of the reference materials available in its online edition of 27 September 2017.
The first step in the collection of blood donations alone – the act of piercing through the donor’s skin which is covered with bacteria – involves the potential risk of pathogens entering the blood donation. For this reason, various measures are in place to ascertain that the blood donation is safe throughout the entire blood donation procedure. These include donor screening, effective disinfection of the punctured site of the skin, and the testing of blood products for possible pathogens.
One of the prerequisites for the reliability of the detection methods used in testing for possible pathogens is their validation by means of suitable reference materials (validated test strains). These are comparable with calibration weights of weighing scales. To serve as reliable reference materials, the test strains survive, and must be replicable under the storage conditions determined.
In addition, for a quantitative validation, it is necessary to know the live pathogen count. To guarantee this, a collaborative trial was performed under the supervision of the Paul-Ehrlich-Institut, to which 14 laboratories contributed, and the results of which have now enabled the Paul-Ehrlich-Institut to extend the repository of WHO reference materials by the following bacterial strains:
• Bacillus cereus PEI-B-P-57
• Bacillus thuringiensis PEI-B-P-07
• Enterobacter cloacae PEI-B-P-43
• Morganella morganii PEI-B-P-91
• Proteus mirabilis PEI-B-P-55
• Pseudomonas fluorescens PEI-B-P-77
• Serratia marcescens PEI-B-P-56
• Staphylococcus aureus PEI-B-P-63
• Streptococcus dysgalactiae PEI-B-P-7
• Streptococcus bovis -reklassifiziert als Streptococcus gallolyticus.
As early as 2011 the Paul-Ehrlich-Institut, in collaboration with the “International Society of Blood Transfusion” (ISBT) developed the first bacterial reference panel of four strains (Staphylococcus epidermidis PEI-B-P-06, Klebsiella pneumoniae PEI-B-P-08, Streptococcus pyogenes PEI-B-P-20 und Escherichia coli PEI-B-P-19) in a worldwide collaborative trial. The full genome sequence of these strains is now known and is publicly available  at the American Society for Microbiology (ASM)
All 14 reference materials are cultured by the Paul-Ehrlich-Institut by means of a method especially developed for this purpose and provided as deep-frozen bacterial suspension with a defined pathogen count.
“I am happy that our researchers have made an important contribution to the reliable testing of blood products worldwide through the development and provision of blood products”, said Professor Klaus Cichutek, president of the Paul-Ehrlich-Institut.
WHO Collaborating Centre at the Paul-Ehrlich-Institut
Since 2005, the Paul-Ehrlich-Institut has a WHO Collaborating Centre for the quality assurance of blood products and in vitro diagnostic devices. The work of the WHO Collaborating Centre is multifaceted. The Paul-Ehrlich-Institut initiates and organises standardisation projects for biological reference materials and takes part in collaborative trials worldwide. Members of staff of the Paul-Ehrlich-Institut take an active part in various expert meetings and working parties of the WHO, and, together with other researchers, prepare regulatory documents (WHO Guidelines). Last but not least, the Paul-Ehrlich-Institut regularly provides the WHO in Geneva with experts as part of a secondment
Spindler-Raffel E, Benjamin RJ, McDonald CP, Ramirez-Arcos S, Aplin K, Bekeredjian-Ding I, de Korte D, Gabriel C, Gathof B, Hanschmann KM, Hourfar K, Ingram C, Jacobs MR, Keil SD, Kou Y, Lambrecht B, Marcelis J, Mukhtar Z, Nagumo H, Niekerk T, Rojo J, Marschner S, Satake M, Seltsam A, Seifried E, Sharafat S, Störmer M, Süßner S, Wagner SJ, Yomtovian R for the ISBT Working Party Transfusion-Transmitted Infectious Diseases (WP-TTID) Subgroup on Bacteria (2017): Enlargement of the WHO international repository for platelet transfusion-relevant bacteria reference strains.
 Mellmann A, Spindler-Raffel E, Bletz S, Prax M, Bekeredjian-Ding I (2017): Genome Sequences of the First WHO Repository of Platelet Transfusion-Relevant Bacterial Reference Strains.
Genome Announc. 2017 Jul 20;5(29)
The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.
Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute.
The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).
Abstract of the publication
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522920/ - Full text Version of the Genome Announc publication
Dr. Susanne Stöcker | idw - Informationsdienst Wissenschaft
Flow of cerebrospinal fluid regulates neural stem cell division
21.05.2018 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Chemists at FAU successfully demonstrate imine hydrogenation with inexpensive main group metal
21.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology